Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Ordinary Shares, par value US$0.0001 per share
-
Shares outstanding
-
759K
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
19.2K
-
Shares change
-
-102K
-
Total reported value, excl. options
-
$24.7K
-
Value change
-
-$130K
-
Number of buys
-
1
-
Number of sells
-
-5
-
Price
-
$1.28
Significant Holders of Haoxi Health Technology Ltd - Class A Ordinary Shares, par value US$0.0001 per share (HAO) as of Q2 2025
7 filings reported holding HAO - Haoxi Health Technology Ltd - Class A Ordinary Shares, par value US$0.0001 per share as of Q2 2025.
Haoxi Health Technology Ltd - Class A Ordinary Shares, par value US$0.0001 per share (HAO) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2K shares
of 759K outstanding shares and own 2.54% of the company stock.
Largest 7 shareholders include CITADEL ADVISORS LLC (14.7K shares), UBS Group AG (4.54K shares), BANK OF AMERICA CORP /DE/ (4 shares), MORGAN STANLEY (0 shares), JPMORGAN CHASE & CO (0 shares), BOOTHBAY FUND MANAGEMENT, LLC (0 shares), and METEORA CAPITAL, LLC (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.